n OAB, the muscles may be affected resulting in involuntary contraction of the muscles, thus leading to incontinence. Solifenacin for treating OAB Solifenacin succinate (trade name Vesicare) tablets are given for managing OAB and represent the standard of care for overactive bladder. Vesicare is marketed

powder) and Tamsulosin XR (extended release capsules) for benign prostate hyperplasia (BPH) that the company is planning to file NDAs for in 2018. Solifenacin DRG granules are being developed for the indication of overactive bladder, and combination TadalafillFinasteride capsules for enlarged prostate and